U.S. Erectile Dysfunction Market & Competitive Landscape - 2018 - ResearchAndMarkets.com

October 5, 2018

DUBLIN--(BUSINESS WIRE)--Oct 5, 2018--The “U.S. Erectile Dysfunction Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering.

U.S. Erectile Dysfunction Market and Competitive Landscape - 2018, provides comprehensive insights into Erectile Dysfunction pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares.This study accurately estimates and forecast Erectile Dysfunction market size and drug sales. This research also provides insights into Erectile Dysfunction epidemiology and late stage pipeline.

Research Scope

Erectile Dysfunction pipeline: Find out the drugs in clinical trials for Erectile Dysfunction by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by companyErectile Dysfunction epidemiology: Find out the prevalence of Erectile Dysfunction in U.S.; prevalence forecast to 2023Erectile Dysfunction products: Identify key products marketed and prescribed for Erectile Dysfunction by brand name, by molecule, by company, by branded / generic, in U.S.Erectile Dysfunction market size: Find out the market size for Erectile Dysfunction drugs in U.S.; Find out how the market advanced from 2014Erectile Dysfunction drug sales: Find out the sales of Erectile Dysfunction drugs in U.S.Erectile Dysfunction drugs sales forecast: Sales forecast for Erectile Dysfunction drugs to 2023 in U.S.Erectile Dysfunction market share analysis: Find out the market shares of Erectile Dysfunction drugs and outlook in U.S.

Key Topics Covered

1. Erectile Dysfunction: Disease Overview

2. Erectile Dysfunction Pipeline Insights

3. Erectile Dysfunction Epidemiology Analysis

4. U.S. Erectile Dysfunction Market Insights

For more information about this report visit https://www.researchandmarkets.com/research/nszkh8/u_s_erectile?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181005005434/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Sexual and Reproductive Health Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/05/2018 01:09 PM/DISC: 10/05/2018 01:09 PM


Update hourly